N-(5-(3,5-Dicyano-1,2,6-trimethyl-1,4-dihydropyridin-4-yl)-6-fluoro-7-methyl-1H-indazol-3-yl)-2-ethylbenzamide

98%

Reagent Code: #214755
fingerprint
CAS Number 2377576-35-5

science Other reagents with same CAS 2377576-35-5

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 468.53 g/mol
Formula C₂₇H₂₅FN₆O
badge Registry Numbers
MDL Number MFCD34662962
thermostat Physical Properties
Boiling Point 617.9±55.0 °C(Predicted)
inventory_2 Storage & Handling
Density 1.32±0.1 g/cm3(Predicted)
Storage 2-8°C, sealed, dry, light-proof

description Product Description

Used in pharmaceutical research as a potent inhibitor of cyclin-dependent kinases (CDKs), particularly CDK2 and CDK9, making it a candidate for anticancer drug development. It shows promise in disrupting cell cycle progression and transcription in tumor cells, especially in hematological malignancies. Its structure enables high selectivity and improved metabolic stability, supporting its evaluation in preclinical studies for targeted cancer therapies.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 50mg
10-20 days ฿22,450.00
inventory 100mg
10-20 days ฿38,160.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
N-(5-(3,5-Dicyano-1,2,6-trimethyl-1,4-dihydropyridin-4-yl)-6-fluoro-7-methyl-1H-indazol-3-yl)-2-ethylbenzamide
No image available

Used in pharmaceutical research as a potent inhibitor of cyclin-dependent kinases (CDKs), particularly CDK2 and CDK9, making it a candidate for anticancer drug development. It shows promise in disrupting cell cycle progression and transcription in tumor cells, especially in hematological malignancies. Its structure enables high selectivity and improved metabolic stability, supporting its evaluation in preclinical studies for targeted cancer therapies.

Used in pharmaceutical research as a potent inhibitor of cyclin-dependent kinases (CDKs), particularly CDK2 and CDK9, making it a candidate for anticancer drug development. It shows promise in disrupting cell cycle progression and transcription in tumor cells, especially in hematological malignancies. Its structure enables high selectivity and improved metabolic stability, supporting its evaluation in preclinical studies for targeted cancer therapies.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...